Molecular imaging using the ¹¹¹In- or ⁶⁸Ga-labeled Affibody molecule ABY-002 has the potential to localize metastatic lesions in vivo, adds qualitative information not available by conventional techniques, and may allow the HER2 status to be determined for metastases not amenable to biopsy. In the patient shown here, a potential metastasis in the chest wall near the axilla was shown with ⁶⁸Ga-ABY-002 but was not visible with ¹⁸F-FDG.
See page 892.